Search results
Results from the WOW.Com Content Network
The COVID-19 pandemic has had many impacts on global health beyond those caused by the COVID-19 disease itself. It has led to a reduction in hospital visits for other reasons. There have been 38 per cent fewer hospital visits for heart attack symptoms in the United States and 40 per cent fewer in Spain. [1]
The most recent COVID-19 vaccine should offer protection against the XEC variant, Russo says. “The most recent version of the vaccine seems to be reasonably well-matched,” he says.
COVID-19 patients may have a higher risk of being diagnosed with a mental illness, such as an anxiety disorder or depression, according to a new study published in the journal the Lancet.. For the ...
Chronic effects of COVID-19 can lead to a prolonged inflammatory state, which can increase symptoms resembling an autoimmune disorder. [1] Many patients with COVID-19 experience psychological symptoms that can arise either from the direct actions of the virus, the chronic increase in inflammation or secondary effects, such as post-traumatic ...
Anxiety and depression have been found to increase susceptibility to marijuana use. [52] This is due to a desire to alleviate the symptoms of these experiences through marijuana use. Chronic users who use for anxiolytic purposes will even develop dependencies on cannabis, making it difficult to cope with anxiety when the drug is absent.
Some 30% of people reported experiencing moderate to severe depressive symptoms in the last two weeks.
COVID-19 increases fear and worries of vulnerability due to the unclear understanding of how COVID-19 impacts pregnancy. A 2020 study in China of 4,124 pregnant women found that after they learned that COVID-19 could be spread from human to human their scores on the Edinburgh Postnatal Depression Scale were much higher.
The psychoactive component of cannabis, tetrahydrocannabinol (THC) is not effective in treating emotion-regulation and anxiety-related symptoms. [20] Conversely, THC has been empirically related to an increase anxiety symptoms through impacts on neurological areas impacting serotonin, noradrenalin, GABA and glutamate.